US 12,410,064 B2
Preparation of soluble compounds
Carla Jehan Catherine Spina, Toronto (CA); and Johanny Elizabeth Notarandrea Alfonzo, Toronto (CA)
Assigned to EXCITON PHARMA CORP., (CA)
Appl. No. 17/599,357
Filed by EXCITON PHARMA CORP., Toronto (CA)
PCT Filed Apr. 9, 2020, PCT No. PCT/CA2020/050485
§ 371(c)(1), (2) Date Sep. 28, 2021,
PCT Pub. No. WO2020/206525, PCT Pub. Date Oct. 15, 2020.
Application 17/599,357 is a continuation of application No. PCT/CA2019/050432, filed on Apr. 9, 2019.
Prior Publication US 2022/0177322 A1, Jun. 9, 2022
Int. Cl. C01G 5/00 (2006.01); A01N 59/16 (2006.01); B01J 23/50 (2006.01); C08K 3/105 (2018.01)
CPC C01G 5/006 (2013.01) [A01N 59/16 (2013.01); B01J 23/50 (2013.01); C01P 2006/90 (2013.01); C08K 3/105 (2018.01)] 13 Claims
OG exemplary drawing
 
1. A method for preparing an oxidized metal complex comprising:
a) providing a species solution comprising a silver periodate complex and having a pH of at least pH 11; and
b) adjusting the pH of the species solution below pH 11 to form a silver diperiodate complex capable of providing enhanced antimicrobial activity compared to a silver periodate complex formed without performing the adjustment.